Suspended

Digital Symptom Tracking, Patient Engagement and Quality of Life in Advanced Cancer

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

Use of Noona web- based symptom tracking tool

Device
Who is being recruted

Over 18 Years
+12 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Services Research Study

Interventional
Study Start: March 2018
See protocol details

Summary

Principal SponsorStanford University
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: March 1, 2018

Actual date on which the first participant was enrolled.

New patients from three cancer care programs (thoracic oncology, gastrointestinal oncology, and palliative care) at two academic institutions (Stanford and UCSF) will be screened for demographic and disease stage data within the patient medical record. Eligible patients will be asked by their oncology team whether they would be interested in participating a study of symptom management in oncology care. Patients who express interest and ability to participate will be interviewed to determine eligibility.

Official TitleDigital Symptom Tracking, Patient Engagement and Quality of Life in Advanced Cancer
NCT05112198
Principal SponsorStanford University
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

41 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Services Research Study

These studies look at how healthcare is delivered, managed, and organized. They aim to improve care quality, patient experience, and access to treatment.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Over 18 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Criteria

8 inclusion criteria required to participate
Individuals (men and women) aged 18 years or older
Biopsy proven (recurrent or metastatic) advanced lung or gastrointestinal cancer
No limit on prior lines of therapy in the metastatic setting
ECOG performance status of 0-2
Show More Criteria
4 exclusion criteria prevent from participating
Concurrent disease or condition that interferes with participation or safety
Non-english speaking, as the application is developed in the english language
Non-castrate resistant prostate cancer
Enrolled in other non-therapeutic or therapeutic clinical trials

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

One single intervention group is designated in this study

This study does not include a placebo group 

Treatment Groups

Group I

Experimental
In addition to usual care for their disease, patients interact with Noona system and system questioners to record their symptoms over a period of 6 months.

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 2 locations

Suspended

Stanford Cancer Institute

Palo Alto, United StatesOpen Stanford Cancer Institute in Google Maps
Suspended

UCSF Helen Diller Medical Center

San Francisco, United States
Suspended2 Study Centers